A physician wants to test the effectiveness of a new allergy medication.The physician consults a researcher who regularly conducts clinical trials.The physician tells the researcher that she has a backlog of 100 patients she is treating effectively with the current leading medication,but who could potentially benefit even more from the new medication.The researcher recommends that the physician do a true experiment because of the availability of
A) a waiting-list control group.
B) a quasi-treatment control group.
C) an excess-demand control group.
D) a convenience control group.

Question

Quizplus · Accepted Answer

A true experiment requires a control group to compare the effectiveness of the new medication to the current leading medication. In this case, the researcher recommends a waiting-list control group, where half of the patients are randomly assigned to receive the new medication while the other half remain on the current medication and serve as a control group. This allows for a direct comparison between the two groups and provides the most valid results. The other options (B, C, and D) are not appropriate for a true experiment design.

A Physician Wants to Test the Effectiveness of a New